Health Affairs January 30, 2023
Minje Park, Rena M. Conti, Marta E. Wosińska, Ergun Ozlem, Wallace J. Hopp, Erin R. Fox

Patients and hospitals routinely cannot access the most basic and essential prescription medications due to shortages of drugs such as amoxicillin, Adderall, saline, and epinephrine. The recent COVID-19 pandemic and associated geopolitical challenges have further highlighted the need to proactively identify and address vulnerabilities in US pharmaceutical supply chains.

Numerous reports have been written by government agencies, academics, think tanks, consulting companies, and other industry participants to systematically identify causes of and potential solutions to these challenges. One of these efforts was Building Resilience into the Nation’s Medical Product Supply Chains, from the National Academies of Sciences, Engineering, and Medicine (NASEM) , to which this article’s authors contributed as authors or consultants. (The report was commissioned in response to Congress’...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Health System / Hospital, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Supply Chain, Technology
Related Articles:
The AI Software Supply Chain Is A Dumpster Fire: Here's What Companies Can Do About It
Supply chain challenges in 2025: 5 things to know
As Supply Chains Go Digital, Cybersecurity Must be Strongest Link
Digital twins: The key to unlocking end-to-end supply chain growth
Why Supply Chain Technology Keeps Failing—And How To Fix It

Share This Article